Comprehensive Healthcare for Pilgrims: Extraordinary Efforts, Advanced Procedures
During the 1445 Hajj season (2024), over 142,000 pilgrims benefited from various healthcare services provided by health centers and hospitals from the beginning of Dhu al-Qi'dah until the 11th of Dhu al-Hijjah. These services included 24 open-heart surgeries, 249 cardiac catheterizations, and 1,006 dialysis sessions. Additionally, 4,082 pilgrims were admitted to hospitals and medical centers to receive necessary care.
These figures illustrate the ongoing advancement in medical capabilities during Hajj seasons. In the 1444 Hajj season (2023), Medina alone recorded 124 surgeries for pilgrims of different nationalities, including 64 cardiac catheterizations, 4 open-heart surgeries, and 56 general surgeries. There were also 122 dialysis sessions provided, and over 4,700 pilgrims visited emergency departments, including critical care cases.
'Saving Lives' Program
Healthcare efforts extend beyond surgeries through pioneering programs and initiatives aimed at comprehensive care. One of the most notable is the 'Saving Lives' program, implemented annually by the Ministry of Health. It offers specialized, free medical services including open-heart surgeries, cardiac catheterizations, dialysis, endoscopy procedures, and other necessary interventions for pilgrims.
Emergency and field medicine services are also significantly reinforced. A modern ambulance fleet is deployed, featuring mobile intensive care units and fully equipped large ambulances for rapid response to emergencies. Dedicated facilities, such as the King Abdulaziz Center for Kidney Diseases in Medina, support vital services like dialysis and can accommodate dozens of sessions daily for pilgrims.
This comprehensive system is further enhanced by multi-language health education, as well as initiatives like the 'Sick Pilgrims Convoy', which transports hospitalized patients to the holy sites to enable them to perform their rituals. These efforts are powered by a massive workforce—approximately 29,000 healthcare, technical, and administrative staff as of 1438 (2017).
Digital Transformation, Health Sector
In parallel with the tremendous efforts in serving pilgrims, Saudi Arabia's health sector is undergoing a comprehensive digital transformation. The goal is to restructure healthcare delivery to be more efficient, effective, and patient-centered. Digital health is a top priority under the Kingdom's Vision 2030 and the National Transformation Program, which aim to harness technology to improve healthcare quality and accessibility.
A cornerstone of this shift is the National e-Health Initiative, designed to enhance the efficiency and effectiveness of the healthcare sector through information technology. It seeks to integrate all health information systems to create a unified electronic health record for every individual in the Kingdom.
This initiative has led to the development of a wide range of digital platforms and applications, including: 'Sehhaty' (My Health): A comprehensive health services portal that allows appointment booking for various services, including COVID-19 testing, remote medical consultations, appointment management, access to e-prescriptions, and personal medical records.
'Seha' (Health): The first platform specializing in remote medical consultations, enabling direct communication between patients and doctors.
'Mawid' (Appointment): Allows users to easily schedule and manage appointments at primary healthcare centers under the Ministry of Health.
Other specialized platforms: 'Tatamman': For monitoring COVID-19 cases. 'Efada': For issuing medical examination certificates for expatriates. 'Wiqaya': For health education and disease prevention.
Healthcare Services
These digital platforms have had a tangible positive impact on the healthcare sector. They have significantly improved access to care, especially in remote areas, enabling patients to receive immediate consultations without visiting healthcare facilities. They've reduced waiting times and travel costs, streamlined health data management, improved care coordination, and reduced medical errors. Additionally, they've played a key role in health awareness, disease prevention, and post-treatment follow-up.
The healthcare services provided during the Hajj season—including advanced surgical procedures—exemplify Saudi Arabia's unwavering commitment to offering the highest standards of care to pilgrims. Simultaneously, the accelerated digital transformation of the health sector reflects an ambitious vision for the future of healthcare in the Kingdom. By leveraging technology to enhance quality, efficiency, and accessibility, Saudi Arabia is serving both citizens and residents alike.
This integration of advanced direct care with innovative digital solutions positions the Kingdom as a global leader in healthcare services.
Related Topics:
Saudi Interior Min.: Tourism Companies Deceive Pilgrims, Encourage Hajj Violations
Riyadh Global Health Exhibition to Bring Together Int'nal Healthcare Experts
Intensive Preparations for Smooth, Safe Hajj Season: Mecca Deputy Governor
New Chapter Unfolded: Saudi Arabia Launches Electronic Intensive Care Unit
Short link :
Post Views: 2
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Argaam
3 days ago
- Argaam
Smile Care opens second dental clinic in Riyadh
Basma Adeem Medical Co. (Smile Care) said it received a license from the Ministry of Health to open its second dental clinic branch, located in Riyadh's Al-Malqa district on Prince Mohammed bin Saad bin Abdulaziz Road. The company said in a statement to Tadawul that the new branch will begin operations and welcome visitors starting today, July 24, 2025, under the Smile Care name. The opening aligns with the board's expansion strategy to strengthen market presence, grow its customer base, and increase market share in the medical sector, while delivering sustainable returns to shareholders, the company added. Smile Care expects the financial impact of the new branch to begin appearing in Q3 2025. It also affirmed its commitment to disclosing any material developments as they arise.
Argaam
3 days ago
- Argaam
Lana secures SAR 10.6M project from Health Ministry
Lana Medical Co. secured a SAR 10.59 million contract from the Ministry of Health to supply hazardous healthcare waste consumables and materials to King Saud Medical City (KSMC), it said in a filing to Tadawul. The 60-month contract will commence following site handover and formal approval by the Ministry of Finance, in line with project documents, technical specifications, and the bill of quantities. The project is a key step in Lana's expansion strategy to offer integrated waste management solutions in the healthcare sector. It focuses on improving environmental service quality, applying global best practices, supporting national pollution-reduction and public health initiatives, and enhancing sustainability by minimizing environmental impact from waste transport and disposal. The company expects the financial impact to appear in Q4 2025, adding that there are no related parties involved in the deal. Lana said the contract reflects its ability to deliver large-scale projects in healthcare facilities to high technical and operational standards. The deal supports its strategy to grow its leadership in Saudi Arabia's environmental services sector and advance Vision 2030 sustainability goals.
Makkah Newspaper
3 days ago
- Makkah Newspaper
Saudi Arabia's Pharma Leap to Global Leadership
Dear reader, over the past decade, Saudi Arabia has undertakenan ambitious overhaul of its healthcare and life sciences landscape. Guided by Vision 2030, the Kingdom is positioning itself as a knowledge‑driven economy with a robust, self‑reliant pharmaceutical sector. Recent data from IQVIA andEuromonitor highlight progress on several key fronts, including market expansion, manufacturing capacity, hospital infrastructure, and tender market dynamics. Here's a closer look at the numbers and why they matter. Across the broader Middle East and Africa (MEA) region, pharmaceutical sales increased from USD 24.2 billion in 2020 to USD 29.5 billion in 2023 and are projected to surpass USD 32.6 billion in 2024, representing a cumulative growth of approximately 35% over the four years. Saudi Arabia is the primary growth driver, with the Kingdom's share increasing from USD 8.7 billion to USD 11.6 billion, underscoring strong domestic demand and rising purchasing power. The UAE, SouthAfrica, and Algeria follow closely, while smaller markets, such as Lebanon, Jordan, and Kuwait, are expanding steadily from a lower base. Dear reader, Zooming in on Saudi Arabia's five largest therapy areas, combined sales rose from about USD 3.8 billion in 2019 to a forecasted USD 5.6 billion by 2026 (a 6.5 % compound annual growth rate). General medicines alone are expected to exceed USD 2.8 billion by 2026, followed by consumer health products at roughly USD 750 million, driven by trends in preventive care and wellness. Dermatology, digestive health, and ophthalmology remain smaller niches, but they are growing at 5–7% per year as urban lifestyles increase demand for allergy treatments and chronic disease medications. Government tenders remain the backbone of public procurement, valued at approximately USD 5.6 billion. Two multinationals, Hikma and Sanofi, lead with 9 % share each. Local champions SPIMACO (8%) and Tabuk Pharmaceuticals (7%) rank closely behind, while Pfizer, Novo Nordisk, and Novartis each hold 5–6%. At the other end of the scale, Jamejoom Pharma captures just 1 %, signaling headroom for domestic firms to ramp up portfolios tailored to tender specifications. Dear reader, domestic production is spreading across a broader base of players (over 2,100 registered items). Pharmaceutical Solution Industries (PSI) tops the chart with 21% of national output, followed by Tabuk (18%) and SPIMACO (15%).Jamejoom, Riyadh Pharma, and Jazeera Pharma each command roughly 8–9 %, while a long tail of other manufacturers together accounts for 20 %. The distribution highlights Ministry of Industry incentives to increase local content, promote innovation, and enhance exports, particularly following the launch of the National Biotechnology Strategy. Dear reader, several forces are converging: sweeping healthcarefinancing reforms, incentives for local manufacturing that deepen supply chain resilience, a welcoming stance toward foreign direct investment, and rapid digital adoption, from telemedicine to e-prescriptions. Although rising healthcare costs and chronic disease burdens pose challenges, current indicators suggest an ample runway for both local and international drugmakers, especially in biologics, targeted therapies, and self-care products. Saudi Arabia is charting a course to become the region's premier hub for pharmaceutical innovation and high‑quality healthcare services. With a sizable domestic market, expanding infrastructure, and policies favorable to private enterprise, the Kingdom could, by the end of the decade, rank among the most attractive healthcare markets in the broader Middle East and North Africa. In short, the 'Saudi pharma leap' is no longer aspirational rhetoric; it is unfolding on the ground. Continued execution will be vital, but the trajectory points to a future where Saudi Arabia not only meets local medical needs more efficiently but also exports health solutions to the world.
